PubMed Health⌕ Search

PubMed · 12605794

[Oral or sublingual nifedipine: utility and long-term effectiveness of medical education to decrease its use in increased blood pressure].

Abstract

OBJECTIVES: Despite the severe side effects reported, short acting nifedipine compounds (oral or sublingual) are still widely used for the considered hypertensive emergencies. The objective of this study was to study the effect of simple medical education measures on the prescription of such compounds in our institution. METHODS: In a previous survey we found that 67% of physicians involved in the care of hypertensive emergencies at our institution considered oral/sublingual nifedipine the therapy of choice. The recommendations in the JNC VI document were reviewed in a Clinical Session and each participating physician was provided with a translated copy and a letter with the reasoned answer. The Pharmacy Department provided a list of patients with the prescriptions of nifedipine upon request and programmed in the Emergency Department, Medical and Surgical Departments. Four time periods were considered: first or control (pre-session): September 1997-March 1998; second (immediately post-session): June 1998-December 1998; third (9-12 months post-session): January 1999-June 1999, and fourth (28-34 months post-session): September 2000-March 2001. At a later session the results were presented and a summary of results was submitted to Departments with a consensus note on the prescription of short acting nifedipine compounds. RESULTS: There were significative decrements in urgent and total doses and treated patients during the periods considered. This effect was sustained and in a three-year period reductions of 78% (Emergency Room), 91% (Medical Services) and 79% (Surgical Services) of prescriptions were noted. CONCLUSIONS: Simple measures of continuous medical education (scientific meetings, personal letters and facilitated access to scientific evidence) were highly effective in reducing prescriptions of short-acting nifedipine at our centre.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Montes Santiago, M T Inaraja Bobo, V del Campo Fernández. 2003. [Oral or sublingual nifedipine: utility and long-term effectiveness of medical education to decrease its use in increased blood pressure].. https://doi.org/10.1157/13042182

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Alginate microparticles as novel carrier for oral insulin delivery.

Alginate microparticles produced by emulsification/internal gelation were investigated as a promising carrier for insulin delivery. The procedure involves the dispersion of alginate solution containing insulin protein, into a water immiscible phase. Gelation is triggered in situ by instantaneous release of ionic calcium from carbonate complex via gentle pH adjustment. Particle size is controlled through the emulsification parameters, yielding insulin-loaded microparticles. Particle recovery was compared using several washing protocols. Recovery strategies are proposed and the influence on particle mean size, morphology, recovery yield (RY), encapsulation efficiency, insulin release profile, and structural integrity of released insulin were evaluated. Spherical micron-sized particles loaded with insulin were produced. The recovery process was optimized, improving yield, and ensuring removal of residual oil from the particle surface. The optimum recovery strategy consisted in successive washing with a mixture of acetone/hexane/isopropanol coupled with centrifugation. This strategy led to small spherical particles with an encapsulation efficiency of 80% and a RY around 70%. In vitro release studies showed that alginate itself was not able to suppress insulin release in acidic media; however, this strategy preserves the secondary structure of insulin. Particles had a mean size lower than the critical diameter necessary to be orally absorbed through the intestinal mucosa followed by their passage to systemic circulation and thus can be considered as a promising technology for insulin delivery.

Administration, Oral↗

Treatment of recurrent pulmonary vein stenoses with endovascular stenting and adjuvant oral sirolimus.

The increasing use of radiofrequency catheter ablation for the cure of atrial fibrillation has led to iatrogenic pulmonary vein stenosis as a new clinical entity. The optimal diagnostic modality and treatment for pulmonary vein stenosis and restenosis remain unclear. We report the successful treatment of pulmonary vein restenosis following percutaneous balloon angioplasty, and for the first time, following surgical bovine pericardial patch angioplasty, with endovascular stenting and adjuvant oral sirolimus. Both patients remain asymptomatic at 1 year follow-up without evidence of restenosis.

Administration, Oral↗

Induction of salivary polypeptides associated with parotid hypertrophy by gallotannins administered topically into the mouse mouth.

Isoproterenol-induced salivary polypeptides (IISP), a group of proline-rich proteins synthesized by mouse parotids, have been considered as markers for isoproterenol-induced parotid hypertrophy. Rodents fed diets containing high-tannin cereals (sorghum), also develop parotid hypertrophy. To test whether tannins are directly involved in provoking sialotrophic growth, we studied the effect of intraperitoneal and topical oral administrations of tannic acid (TA) on the induction of IISP polypeptides in endogamic mice (A/Snell). TA was characterized by HPLC chromatography and spectral analysis and shown to be composed solely of gallotannins, a complex family of glucose and gallic acid esters. IISP polypeptides were monitored in saliva by SDS-polyacrylamide gel electrophoresis during 36 h after ending TA stimulation. Single daily intraperitoneal administrations of TA for 3 consecutive days (0.033 mg/g bw/day), at variance of parallel administrations of isoproterenol (0.042 mg/g bw/day) failed to induce IISP polypeptides. However, repeated topical applications of TA into the mouse mouths (1.21 mg/g bw divided into three equal doses given at 4-h intervals within a single day) resulted in unequivocal induction of IISP polypeptides. That response was clearly intensified by increasing the stimulation frequency to eight equivalent doses given at 1.5-h intervals within a single day (corresponding to 3.23 mg/g bw) and even further by repeating this protocol for 3 days. Under these productive schemes of stimulations by TA, electrophoretic fractionation of parotid homogenates showed new polypeptide bands migrating in parallel to salivary IISP. These results suggest that topically administered gallotannins are effective inducers of trophic growth in mouse parotids.

Administration, Oral↗